Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026)
Sera Prognostics (SERA) posted Current Deferred Revenue of $20.3 million for Q1 2026, little changed on a QoQ basis from $20.3 million in Q4 2025, and little changed year-over-year from $20.2 million in Q1 2025.
Sera Prognostics (SERA) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Sera Prognostics' Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $20.3 million for Q1 2026.
- Quarterly Current Deferred Revenue changed 0.44% year-over-year to $20.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.3 million (changed 0.44% YoY) and the FY2025 annual result came in at $20.3 million, changed 0.45% from the prior year.
- Current Deferred Revenue was $20.3 million for Q1 2026 at Sera Prognostics, roughly flat from $20.3 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $20.3 million in Q3 2025 and bottomed at $3.1 million in Q2 2022.
- A 5-year average of $16.1 million and a median of $20.2 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 6433.81% — and 2024, when it declined 0.06%.
- Sera Prognostics' Current Deferred Revenue stood at $9.1 million in 2022, then jumped by 122.8% to $20.2 million in 2023, then decreased by 0.06% to $20.2 million in 2024, then gained by 0.45% to $20.3 million in 2025, then decreased by 0.02% to $20.3 million in 2026.
- Business Quant data shows SERA's Current Deferred Revenue at $20.3 million in Q1 2026, $20.3 million in Q4 2025, and $20.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sera Prognostics | 109.06 Mn | 109.06 Mn | -28,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.31 Mn |
| Dec 31, 2025 | 20.32 Mn |
| Sep 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 20.22 Mn |
| Mar 31, 2025 | 20.22 Mn |
| Dec 31, 2024 | 20.22 Mn |
| Sep 30, 2024 | 20.23 Mn |
| Jun 30, 2024 | 20.23 Mn |
| Mar 31, 2024 | 20.23 Mn |
| Dec 31, 2023 | 20.24 Mn |
| Sep 30, 2023 | 9.04 Mn |
| Jun 30, 2023 | 9.05 Mn |
| Mar 31, 2023 | 9.07 Mn |
| Dec 31, 2022 | 9.08 Mn |
| Jun 30, 2022 | 3.10 Mn |
| Dec 31, 2021 | 139,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 138,000.00 |